Las enfermedades alérgicas suponen un coste directo de entre 1.800 y 6.600 euros por paciente al año
June 02, 2024 17:07 ET
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, June 02, 2024 (GLOBE NEWSWIRE) -- Las enfermedades alérgicas suponen un coste de entre 1.823 y 6.656 euros por paciente al año si solo tenemos en cuenta los gastos directos...
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
June 02, 2024 17:07 ET
|
European Academy of Allergy and Clinical Immunology
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Arranca en Valencia el Congreso de la EAACI
May 31, 2024 13:11 ET
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, May 31, 2024 (GLOBE NEWSWIRE) -- Con el lema “Revolucionando la atención al paciente a través del poder de la ciencia de los datos”, ha comenzado el congreso internacional...
EAACI Congress Kicks Off in Valencia, Spain
May 31, 2024 13:11 ET
|
European Academy of Allergy and Clinical Immunology
EAACI Congress Kicks Off in Valencia, Spain
Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
Presentación del Congreso de la Academia Europea de Alergología e Inmunología Clínica (EAACI) que se celebrará en Valencia del 31 de mayo al 3 de junio
May 30, 2024 09:37 ET
|
European Academy of Allergy and Clinical Immunology
VALENCIA, España, May 30, 2024 (GLOBE NEWSWIRE) -- Con el lema «Revolucionando la atención al paciente a través del poder de la ciencia de los datos», el congreso destacará el papel...
Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3
May 30, 2024 09:37 ET
|
European Academy of Allergy and Clinical Immunology
We are delighted to invite you to the opening press conference of our EAACI Annual Congress 2024 in Valencia or online via the link below.
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
May 23, 2024 08:47 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and...
Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises
May 22, 2024 08:30 ET
|
Biodexa Pharmaceuticals PLC
May 22, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises Proceeds Cover Year 1 eRapa Phase 3 Obligations, Unlocking...
Wugen Announces RMAT and PRIME Designations for WU-CART-007 to Accelerate Regulatory Reviews and Plans to Present Positive Phase 2 Study Findings at European Hematology Association (EHA) 2024 in June
May 20, 2024 07:03 ET
|
Wugen
Wugen Announces RMAT and PRIME Designations for WU-CART-007 and Plans to Present Positive Phase 2 Study Findings at EHA 2024